toc_master update january 7

7/27/2019 TOC_Master Update January 7

1/12

PHARMACOTHERAPY 9/E - Table of Contents

9/e Ch. # Chapter Title

1st Draft

Received

Foundation Issues

Pharmacoeconomics: Principles, Methods, and Applications

Health Outcomes and Quality of Life

W1 Health Literacy

W2 Cultural Competency

W3 Medication Safety yes

W4 Evidence-Based Medicine

Documentation of Pharmacy Services

W5Pharmacokinetics yes

W6 Pharmacogenetics yes

W7 Pediatrics yes

W8 Geriatrics yes

W9 Palliative Care

Pharmacoepidemiology

W10 Clinical Toxicology yes

W11 Biological Terrorism yes

W12 Chemical and Radiological Terrorism yes

Organ-Specific Function Tests and Drug-Induced Diseases

1 Cardiovascular Testing yes

W13 Pulmonary Function Testing yes

W14 Drug-Induced Pulmonary Disease yes

W15 Evaluation of the Gastrointestinal Tract

Drug therapy individualization for patients with hepatic disease

or altered drug-metabolizing status

W16 Drug-Induced Liver Disease yes

W17 Quantification of Renal Function 31-Oct

W18 Evaluation of Neurological Illness yes

W19 Evaluation of Psychiatric Illness yes

W20 Function and Evaluation of the Immune System

W21 Allergic and Pseudoallergic Drug Reactions yes


2/12

W22

Dermatologic Drug Reactions, Self-Treatable Skin Disorders,

and Skin Cancer

W23 Drug-Induced Hematologic Disorders yes

W24 Laboratory Tests to Direct Antimicrobial Pharmacotherapy yes

1 Cardiovascular Disorders

1 Cardiovascular Testing

2 Cardiopulmonary Arrest

3 Hypertension

4 Chronic Heart Failure

Diastolic Heart Failure

5 Acutely Decompensated Heart Failure yes

6 Ischemic Heart Disease

7 Acute Coronary Syndromes

8 Arrhythmias

9 Venous Thromboembolism yes

10 Stroke

11 Hyperlipidemia

12 Peripheral Arterial Disease

13 Use of Vasopressors and Inotropes in Pharmacotherapy of Shock

14 Hypovolemic Shock

2 Respiratory Disorders

15 Asthma

16 Chronic Obstructive Pulmonary Disease yes

17 Pulmonary Artery Hypertension

18 Cystic Fibrosis yes

3 Gastrointestinal Disorders

19 Gastroesophageal Reflux Disease yes

20 Peptic Ulcer Disease

21 Inflammatory Bowel Disease yes

22 Nausea and Vomiting yes

23 Diarrhea, Constipation, and Irritable Bowel Syndrome yes

24 Portal Hypertension and Cirrhosis yes

25 Pancreatitis yes

26 Viral Hepatitis

27 Celiac Disease yes

4 Renal Disorders


3/12

28 Acute Renal Failure yes

29

Chronic Kidney Disease: Progression-Modifying Therapies

yes

Chronic Kidney Disease: Management of Complications

30 Hemodialysis and Peritoneal Dialysis yes

31 Drug-Induced Kidney Disease LATE

32 Glomerulonephritis LATE

33

Drug Therapy Individualization for Patients with Renal

Insufficiency yes

34 Disorders of Sodium and Water Homeostasis LATE

35 Calcium and Phosphorus Homeostatis 15-Nov

36 Potassium and Magnesium Homeostasis YES

37 Acid-Base Disorders YES

5 Neurologic Disorders

38 Alzheimer's Disease

39 Multiple Sclerosis yes

40 Epilepsy yes

41 Status Epilepticus yes

42 Acute Management of the Brain Injury Patient yes

43 Parkinson's Disease yes

44 Pain Management yes

45 Headache Disorders yes

6 Psychiatric Disorders

46 Attention-Deficit/Hyperactivity Disorder yes

47 Eating Disorders yes

48

Substance-Related Disorders: Overview and Depressants,

Stimulants, and Hallucinogens yes

49 Substance-Related Disorders: Alcohol, Nicotine, and Caffeine yes

50 Schizophrenia yes

51 Depressive Disorders yes

52 Bipolar Disorder yes

53

Anxiety Disorders I: Generalized Anxiety Disorder, Panic, and

Social Anxiety Disorders yes

54

Anxiety Disorders II: Posttraumatic Stress Disorder and

Obcessive-Compulsive Disorder yes

55 Sleep Disorders yes

56 Developmental Disabilities yes


4/12

7 Endocrinologic Disorders

57 Diabetes Mellitus

58 Thyroid Disorders

59 Adrenal Gland Disorders

60Pituitary Gland Disorders

8 Gynecologic and Obstetric Disorders

61 Pregnancy and Lactation yes

62 Contraception yes

63 Menstrual-Related Disorders yes

64 Endometriosis yes

65 Hormone Therapy in Women yes

9 Urologic Disorders

66 Erectile Dysfunction

67 Benign Prostatic Hyperplasia68 Urinary Incontinence

10 Immunologic Disorders

69 Systemic Lupus Erythematosus

70 Solid Organ Transplantation 15-Nov

11 Rheumatologic Disorders

71 Osteoarthritis yes

72 Rheumatoid Arthritis

73 Osteoporosis and Osteomalacia

74 Gout and Hyperuricimia yes12 Ophthalmic and Otolaryngological Disorders

75 Glaucoma yes

76 Allergic Rhinitis yes

13 Dermatologic Disorders

77 Acne Vulgaris yes

78 Psoriasis

79 Atopic Dermatitis

14 Hematologic Disorders

80 Anemias81 Coagulation Disorders yes

82 Sickle cell anemia

15 Infectious Diseases

83 Antimicrobial Regimen Selection yes

84 Central Nervous System Infections yes


5/12

85 Lower Respiratory Tract Infections yes

86 Upper Respiratory Tract Infections yes

87 Influenza yes

88 Skin and Soft Tissue Infections yes

89Infective Endocarditis yes

90 Tuberculosis yes

91 Gastrointestinal Infections and Enterotoxigenic Poisonings yes

92 Intra-abdominal Infections

93 Parasitic Diseases yes

94 Urinary Tract Infections yes

95 Sexually Transmitted Diseases yes

96 Bone and Joint Infections yes

97 Sepsis and Septic Shock yes

98 Superficial Fungal Infections99 Invasive Fungal Infections yes

100 Infections in Immunocompromised Patients yes

101 Antimicrobial Prophylaxis in Surgery yes

102 Vaccines, Toxoids, and Other Immunobiologics yes

103 Human Immunodeficiency Virus

16 Oncologic Disorders

104 Cancer Treatment and Chemotherapy

105 Breast Cancer

106 Lung Cancer107 Colorectal Cancer

108 Prostate Cancer yes

109 Lymphomas yes

110 Ovarian Cancer

111 Acute Leukemias

112 Chronic Leukemias yes

113 Multiple Myeloma

114 Myelodysplastic Syndromes

115 Renal Cell Carcinoma yes116 Melanoma

117 Hematopoietic Stem Cell Transplantation

17 Nutritional Disorders

118 Assessment of Nutrition Status and Nutrition Requirements yes

Medication Considerations with Specialized Nutrition Support


6/12

119 Parenteral Nutrition yes

120 Enteral nutrition YES

Nutritional Considerations in Major Organ Failure

121 Obesity YES

Total print pages


7/12

Ed has

made

Comments 2nd and Final Draft Ready for McGraw

yes

YES

YES YES

YES YES

yes yes

yes yes yes

YES

yes yes yes

yes yes yes


8/12

8/15/2012

9/25/2012

9/13/2012

8/30/2012

12-Sep

12-Sep

12-May

yes yes

yes yes yes

yes yes yes

yes yes yes

yes yes yes


9/12

YES

YES

yes YES

YES

YES YES

childhood disorder first draft done

yes yes

yes yes

yes yes yes

yes yes yes

yes yes

yes yes

yes yes

yes yes yes

yes yes yes

yes yes

yes yes

yes

yes

yes yes

yes

yes yes

yes yes yes

yes yes yes


10/12

8/3/2012

yes yes

yes yes

yes

yes yes yes

yes

yes

yes

yes

yes

yes yes yes

yes yes yes


11/12

yes yes yes

yes yes yes

yes yes yes

yes yes yesyes yes yes

yes yes yes

yes yes yes

yes yes yes

yes YES yes

yes yes

yes yes yes

yes YES yes

yes YES yes

YES


12/12

YES

YES

toc_master update january 7

Documents